Alzheimer’s is a devastating disease impacting millions of families and our nation’s economy. The only way to change this is through research.

That is why the Alzheimer’s Association, working with and through the Alzheimer’s Impact Movement (AIM), is leading the way to increase research funding at the federal and state level.

We have propelled the federal government to rise to this challenge, resulting in a more than seven-fold increase in federal Alzheimer’s and dementia research funding since 2011 — including a $300 million increase for Alzheimer’s research at the National Institutes of Health (NIH) for fiscal year 2021. With this increase, along with previous research investments, the NIH is expected to spend $3.1 billion on Alzheimer’s research in 2021.

State and local funding

The Association and AIM are also working across the 50 states and the District of Columbia to encourage investment by state and local governments. Through the development and implementation of state Alzheimer’s plans, additional resources are being invested through state grants and appropriations to advance the field and better serve those with the disease in their state.

In 2019, our work secured over $100 million in state funding for dementia-specific care and support services, research, public health activities, home and community-based services and other areas, to meet the needs of individuals and families living with dementia.